Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry
International Journal of Environmental Research and Public Health · 16.02.2023 · 20 (4) · 3522
DOI: 10.3390/ijerph20043522 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 16.02.2023. Verfasst von Haiyan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine Pek…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Biological Products. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences (CIFMS), Chinese National Key Technology R&D Program, Ministry of Science and Technology, Beijing Municipal Science & Technology Commission.
Abstract (Originalsprache)
Background
To estimate the annual direct costs and cost-drivers associated with systemic lupus erythematosus (SLE) patients in China.
Methods
A multi-center, cross-sectional study was conducted based on the CSTAR registry. The information on demography and expenditures for outpatient and inpatient visits due to SLE were collected using online questionnaires. These patients’ medical records were from the database of the Chinese Rheumatology Information System (CRIS). The average direct costs and 95% confidence interval were estimated using the bootstrap method with 1000 bootstrap samples by resampling with replacement. The cost-drivers were identified using multivariate regression models.
Results
A total of 1778 SLE patients from 101 hospitals participated in our study, with 92.58% as females, a mean age of 33.8 years old, a median duration of SLE of 4.9 years, 63.8% in an active disease state, 77.3% with two organs or more damaged, and 8.3% using biologics as treatment. The average annual direct cost per patient was estimated at CNY 29,727, which approximates to 86% for direct medical costs. For moderate to severe disease activities, the use of biologics, hospitalization, treatment of moderate or high dose glucocorticoids, and peripheral vascular, cardiovascular, and/or renal system involvements were found to substantially increase the direct costs, while health insurance slightly decreased the direct costs of SLE.
Conclusions
This study provided reliable insight into financial pressures on individual SLE patients in China. The efforts focusing on preventing flare occurrences and limiting disease progression were recommended to further reduce the direct cost of SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
- Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of…
ORCID-Profile: Yanhong Wang
Förderung
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- Chinese National Key Technology R&D Program, Ministry of Science and Technology
- Beijing Municipal Science & Technology Commission
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Wang, H., Li, M., Zou, K., Wang, Y., Jia, Q., Wang, L., Zhao, J., Wu, C., Wang, Q., Tian, X., Wang, Y., & Zeng, X. (2023). Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry. International Journal of Environmental Research and Public Health, 20(4), 3522. https://doi.org/10.3390/ijerph20043522
Vancouver
Wang H, Li M, Zou K, Wang Y, Jia Q, Wang L, et al. Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry. International Journal of Environmental Research and Public Health. 2023;20(4):3522. doi:10.3390/ijerph20043522
BibTeX
@article{Wang2023,
author = {Wang, Haiyan and Li, Mengtao and Zou, Kaiwen and Wang, Yilin and Jia, Qiaoling and Wang, Li and Zhao, Jiuliang and Wu, Chanyuan and Wang, Qian and Tian, Xinping and Wang, Yanhong and Zeng, Xiaofeng},
title = {Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
volume = {20},
number = {4},
pages = {3522},
doi = {10.3390/ijerph20043522}
}
EUVIMED